• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈萨克斯坦阿克托贝地区 2009 年至 2018 年胃癌发病情况:发病率、趋势及 5 年生存率。

Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival.

机构信息

West Kazakhstan Marat Ospanov Medical University, 68, Maresyev Street, Aktobe, Kazakhstan.

Tbilisi State Medical University, 33, Vazha-Pshavela Ave., Tbilisi, Georgia.

出版信息

Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1645-1652. doi: 10.31557/APJCP.2020.21.6.1645.

DOI:10.31557/APJCP.2020.21.6.1645
PMID:32592359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568899/
Abstract

OBJECTIVE

to assess the current state of gastric cancer (GC) incidence and its five-year survival across Aktobe region of western Kazakhstan from 2009 to 2018 by presenting key indicators and analyzing the most significant features.

METHODS

Rough incidence rates (per 100,000) and average annual percent changes (aAPCs) were estimated for each age group at diagnosis with respect to gender, ethnicity, residence, the disease stages, tumor subsite, and histology type using linear regression analysis, including the prognostic index for 2019-2020. Overall five-year survival rates were estimated by the Kaplan-Meier method.

RESULTS

Overall GC incidence increased from 19.2 to 29.3, and averaged 25.8 (R2 0.65) with aAPC of 3.2%, with a potential to further rise (30.4 by 2020, p<0.001). Non-cardia location (17.8, p<0.001, aAPC 6.4%) and intestinal type of the tumor (17.0, p<0.001, aAPC 7.35%) were predominant. The observed overall five-year survival rate was 28.4% (95% CI 24.5;32.3) with a median survival time of 8.0 months (95% CI 6.6;9.4). Groups aged 40-49 and ≥70 had the lowest rates (24.4% and 22.1%, respectively, log-rank p 0.008), but the youngest individuals (18-39 years) showed the shortest median survival time, 5.0 months after diagnosis at the survival rate of 29.4%. Resectional surgery contributed significantly to the median survival time, 23.0 months vs. 6.0 in non-operated patients (log-rank p<0.001).

CONCLUSION

GC in Aktobe region was featured by growing incidence and unsatisfactory five-year survival rates. Indigenous males of 60-69 years old with intestinal histology type, as well as the youngest patients irrespective of their gender, ethnicity, and other characteristics were recognized as high risk groups. Besides, relatively high aAPC 5.1% in the youngest revealed their further expected vulnerability. Further research is suggested to focus on risk factors, including gene expression profiling, to find out an accessible preventive strategy.
.

摘要

目的

通过呈现关键指标并分析最重要的特征,评估 2009 年至 2018 年哈萨克斯坦西部阿克托贝地区胃癌(GC)的发病情况及其五年生存率。

方法

使用线性回归分析,按性别、种族、居住地、疾病分期、肿瘤部位和组织学类型,对每个诊断年龄组的粗略发病率(每 10 万人)和平均年百分比变化(aAPC)进行估计,包括 2019-2020 年的预后指数。使用 Kaplan-Meier 方法估计总体五年生存率。

结果

GC 的总发病率从 19.2 增加到 29.3,平均为 25.8(R2 0.65),aAPC 为 3.2%,有进一步上升的趋势(2020 年为 30.4,p<0.001)。非贲门部位(17.8,p<0.001,aAPC 6.4%)和肠型肿瘤(17.0,p<0.001,aAPC 7.35%)占主导地位。观察到的总体五年生存率为 28.4%(95%CI 24.5;32.3),中位生存时间为 8.0 个月(95%CI 6.6;9.4)。40-49 岁和≥70 岁的人群的生存率最低(分别为 24.4%和 22.1%,log-rank p 0.008),但最年轻的个体(18-39 岁)的中位生存时间最短,诊断后 5.0 个月的生存率为 29.4%。切除术对中位生存时间有显著影响,23.0 个月与未手术患者的 6.0 个月相比(log-rank p<0.001)。

结论

阿克托贝地区的 GC 发病率不断上升,五年生存率不理想。60-69 岁的土著男性、肠型组织学类型的患者以及无论性别、种族和其他特征如何的最年轻患者,均被认为是高危人群。此外,最年轻的患者 aAPC 相对较高(5.1%),这表明他们未来可能会更加脆弱。建议进一步研究的重点是危险因素,包括基因表达谱,以找到可行的预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/39e4c0fd67d7/APJCP-21-1645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/cd7758b79fd0/APJCP-21-1645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/101856ea231f/APJCP-21-1645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/b208e27ec808/APJCP-21-1645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/a2293180cf93/APJCP-21-1645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/745e9a74e3f0/APJCP-21-1645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/39e4c0fd67d7/APJCP-21-1645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/cd7758b79fd0/APJCP-21-1645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/101856ea231f/APJCP-21-1645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/b208e27ec808/APJCP-21-1645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/a2293180cf93/APJCP-21-1645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/745e9a74e3f0/APJCP-21-1645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c073/7568899/39e4c0fd67d7/APJCP-21-1645-g006.jpg

相似文献

1
Gastric Cancer in Aktobe Region of Western Kazakhstan from 2009 to 2018: Incidence Rates, Trends, and Five-Year Survival.哈萨克斯坦阿克托贝地区 2009 年至 2018 年胃癌发病情况:发病率、趋势及 5 年生存率。
Asian Pac J Cancer Prev. 2020 Jun 1;21(6):1645-1652. doi: 10.31557/APJCP.2020.21.6.1645.
2
Incidence trends and disparities in related malignancy among US adults, 2000-2019.2000-2019 年美国成年人相关恶性肿瘤的发病趋势和差异。
Front Public Health. 2022 Nov 28;10:1056157. doi: 10.3389/fpubh.2022.1056157. eCollection 2022.
3
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.成纤维细胞生长因子受体4蛋白表达与胃癌的临床病理特征
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.
4
Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden.胃腺癌的生存趋势:瑞典的一项基于人群的研究。
Ann Surg Oncol. 2018 Sep;25(9):2693-2702. doi: 10.1245/s10434-018-6627-y. Epub 2018 Jul 9.
5
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
Study on Breast Cancer in Kazakhstan Using the Functional Time Series.哈萨克斯坦乳腺癌的功能时间序列研究
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):1037-1046. doi: 10.31557/APJCP.2023.24.3.1037.
8
Global Incidence and Mortality of Gastric Cancer, 1980-2018.全球 1980-2018 年胃癌发病率和死亡率。
JAMA Netw Open. 2021 Jul 1;4(7):e2118457. doi: 10.1001/jamanetworkopen.2021.18457.
9
Trends of older gastric cancer incidence, mortality, and survival in the highest gastric cancer risk area in China: 2010-2019 and prediction to 2024.中国最高胃癌风险地区 2010-2019 年老年胃癌发病率、死亡率和生存率趋势:2024 年预测
BMC Public Health. 2024 Sep 9;24(1):2449. doi: 10.1186/s12889-024-19944-2.
10
АIR POLLUTION EMISSIONS ARE ASSOCIATED WITH INCIDENCE AND PREVALENCE OF BREAST CANCER IN THE AKTOBE REGION OF WESTERN KAZAKHSTAN.空气污染排放与哈萨克斯坦西部阿克托贝地区乳腺癌的发病率和患病率有关。
Georgian Med News. 2021 Dec(321):135-140.

引用本文的文献

1
A Study of the Effectiveness of Apoptosis Biomarkers in the Diagnosis of Gastric Cancer in Kazakhstan: A Review of Systematic Evidence.哈萨克斯坦胃癌诊断中凋亡生物标志物有效性的研究:系统证据综述
Med J Islam Repub Iran. 2025 Apr 23;39:59. doi: 10.47176/mjiri.39.59. eCollection 2025.

本文引用的文献

1
Disparities in Epidemiological Profile of Gastric Adenocarcinoma in Selected Cities of Brazil.巴西部分城市胃腺癌流行病学特征的差异
Asian Pac J Cancer Prev. 2019 Aug 1;20(8):2253-2258. doi: 10.31557/APJCP.2019.20.8.2253.
2
Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.从西方和东方的角度识别胃癌监测的高危个体:值得借鉴的经验教训以及为日常实践开发综合方法的可能性。
World J Gastroenterol. 2019 Jul 21;25(27):3546-3562. doi: 10.3748/wjg.v25.i27.3546.
3
Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake.
超加工饮食导致热量摄入过量和体重增加:随意进食的住院患者随机对照试验。
Cell Metab. 2019 Jul 2;30(1):67-77.e3. doi: 10.1016/j.cmet.2019.05.008. Epub 2019 May 16.
4
Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家 1990 年至 2017 年饮食风险对健康的影响:2017 年全球疾病负担研究的系统分析。
Lancet. 2019 May 11;393(10184):1958-1972. doi: 10.1016/S0140-6736(19)30041-8. Epub 2019 Apr 4.
5
Epidemiology of gastric cancer: global trends, risk factors and prevention.胃癌流行病学:全球趋势、风险因素与预防
Prz Gastroenterol. 2019;14(1):26-38. doi: 10.5114/pg.2018.80001. Epub 2018 Nov 28.
6
CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.CDH1基因与遗传性弥漫性胃癌综合征:分子与组织学改变及其对诊断和治疗的意义
Front Pharmacol. 2018 Dec 5;9:1421. doi: 10.3389/fphar.2018.01421. eCollection 2018.
7
Differences in gastric cancer surgery outcome between East and West: differences in surgery or different diseases?东西方胃癌手术结果的差异:手术差异还是疾病差异?
J BUON. 2018 Sep-Oct;23(5):1210-1215.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.早期遗传咨询和无症状携带者中 CDH1 突变的检测可提高遗传性弥漫性胃癌的生存率。
Surgery. 2018 Oct;164(4):754-759. doi: 10.1016/j.surg.2018.05.059. Epub 2018 Aug 23.
10
Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden.胃腺癌的生存趋势:瑞典的一项基于人群的研究。
Ann Surg Oncol. 2018 Sep;25(9):2693-2702. doi: 10.1245/s10434-018-6627-y. Epub 2018 Jul 9.